{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["McFall AM"],"funding":["National Institute of Allergy and Infectious Diseases","The William F. Milton Fund","NIDA NIH HHS","NIAID NIH HHS","The Thrasher Research Fund","Center for AIDS Research, Johns Hopkins University","Johns Hopkins University Center for AIDS Research","National Institute on Drug Abuse"],"pagination":["745-755"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11907330"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["120(4)"],"pubmed_abstract":["<h4>Aims</h4>The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association of trajectory membership with HIV testing among people who inject drugs in India.<h4>Design, setting and participants</h4>The study comprised group-based trajectory modeling using longitudinal clinic-based MOUD use data, set in seven Indian cities with integrated care centers (ICC) delivering MOUD, predominantly buprenorphine, in 2018-2019. A total of 1562 people who inject drugs who initiated MOUD for the first time at an ICC between 1 January 2018 and 31 December 2018 were included in this study. Median age was 26 years, 98% were male and 22% were living with HIV.<h4>Measurements</h4>Daily "],"journal":["Addiction (Abingdon, England)"],"pubmed_title":["Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic-based data."],"pmcid":["PMC11907330"],"funding_grant_id":["R01 DA049301","R01DA041034","K23DA057151","R01 DA041034","P30AI094189","K23 DA057151","1P30AI094189","P30 AI094189"],"pubmed_authors":["Gunaratne MP","Srikrishnan AK","Lucas GM","Anand S","Vasudevan CK","McFall AM","Ganapathi L","Solomon SS","Mehta SH"],"additional_accession":[]},"is_claimable":false,"name":"Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic-based data.","description":"<h4>Aims</h4>The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association of trajectory membership with HIV testing among people who inject drugs in India.<h4>Design, setting and participants</h4>The study comprised group-based trajectory modeling using longitudinal clinic-based MOUD use data, set in seven Indian cities with integrated care centers (ICC) delivering MOUD, predominantly buprenorphine, in 2018-2019. A total of 1562 people who inject drugs who initiated MOUD for the first time at an ICC between 1 January 2018 and 31 December 2018 were included in this study. Median age was 26 years, 98% were male and 22% were living with HIV.<h4>Measurements</h4>Daily ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Apr","modification":"2025-07-04T03:05:59.833Z","creation":"2025-04-06T10:46:16.312Z"},"accession":"S-EPMC11907330","cross_references":{"pubmed":["39604070"],"doi":["10.1111/add.16713"]}}